Ortho values IPO at up to $1.6B-plus

Ortho Clinical Diagnostics Holdings PLC, the Raritan-based in vitro diagnostics company, has announced the details of its initial public offering, which could be worth more than $1.6 billion. Ortho said in a news release that it is offering 70 million ordinary shares at a price between $20 and $23 per...